CD8A and neoplasm: Notably, NK cells can also express PD-1, while the expression of PD-1 ligand (PD-L1) limits the delivery of antigens to CD8+T cells by DCs, so the anti-tumor immune response can be promoted by hindering the PD-1/PDL1 axis (34).